ARCHIVES

FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart

This article is from The Cancer Letter archive.

Vol. 36 No. 44 | December 3, 2010

Download PDF Visit The Full Archive

Related Articles

DCCP Board Okays Noncompetitive Procurements

June 11, 1982

Substance From Sea Squirts In Phase II For Breast Cancer

November 29, 2002

In Brief: Tipping Resigns Forom ACS; Vaughan Joins UAB BMT Program; PCI Recruits Ball, Finn, Mirro

September 20, 1991

Centers Program Debate Turns Into Full Review Of All issues; Massive Survey, Hearings Planned

October 23, 1987

Overdiagnosis Can Result In Harm To Patients, Experts Say.

November 3, 2006

NTP Board Approves Concept For New Mutagenesis Assays

January 1, 1988